Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- TatchSleep as a Tool to Aid in Sleep Apnea Analysis: Complete Statistical AnalysisIndependent statistical analysis of TatchSleep as a Tool to Aid in Sleep Apnea Analysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04419714).
- Taxol Carboplatin and Erythropoetin: Complete Statistical AnalysisIndependent statistical analysis of Taxol Carboplatin and Erythropoetin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00158379).
- TAXUS Libertē Post Approval Study: Complete Statistical AnalysisIndependent statistical analysis of TAXUS Libertē Post Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00997503).
- TAXYNERGYIndependent statistical analysis of Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC): primary endpoint results, effect estimate with…
- TAZPOWERIndependent statistical analysis of A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TB31FIndependent statistical analysis of Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04238689).
- TBICIndependent statistical analysis of Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02712996).
- TBKT_HEPIndependent statistical analysis of Thera-Band® HEP for LBP Secondary Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02355275).
- TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients: Complete Statistical AnalysisIndependent statistical analysis of TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00867139).
- TCAPIndependent statistical analysis of Ticagrelor in Severe Community Acquired Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01998399).
- TCM-700CIndependent statistical analysis of The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TCM-PTSDIndependent statistical analysis of Telephone Case Monitoring (TCM) for Veterans With Post-Traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TCM-TMDIndependent statistical analysis of Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID: Complete Statistical AnalysisIndependent statistical analysis of TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TD-0903 for ALI Associated With COVID-19: Complete Statistical AnalysisIndependent statistical analysis of TD-0903 for ALI Associated With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04402866).
- Tdap Vaccine in Post-Partum Women: Complete Statistical AnalysisIndependent statistical analysis of Tdap Vaccine in Post-Partum Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01711645).
- Tdap Vaccine Safety for Plasma Donors: Complete Statistical AnalysisIndependent statistical analysis of Tdap Vaccine Safety for Plasma Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04142983).
- TdBTSIndependent statistical analysis of Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- tDCSIndependent statistical analysis of Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01636661).
- tdcsIndependent statistical analysis of Use of Transcranial Direct Current Stimulation (tDCS) Coupled With Constraint Induced Movement Therapy in Stroke Patient: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- tDCS and Glucose Uptake in Leg Muscles: Complete Statistical AnalysisIndependent statistical analysis of tDCS and Glucose Uptake in Leg Muscles: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04016844).
- tDCS in Elderly Fallers Study: Complete Statistical AnalysisIndependent statistical analysis of tDCS in Elderly Fallers Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03814304).
- tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TDCS-FOGIndependent statistical analysis of Transcranial Direct Current Stimulation for Freezing of Gait: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266004).
- TDCSSCHIZIndependent statistical analysis of Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TEAIndependent statistical analysis of Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04349891).
- TEACOIndependent statistical analysis of TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00296816).
- TEAMIndependent statistical analysis of A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TEAMIndependent statistical analysis of A Phase III Trial of e-TNS for the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TEAMIndependent statistical analysis of An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with…
- TEAMIndependent statistical analysis of Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TEAMIndependent statistical analysis of Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane: primary endpoint results, effect estimate with confidence interval,…
- TEAMIndependent statistical analysis of Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TEAMIndependent statistical analysis of Trial on Endovascular Aneurysm Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00537134).
- Team Science (The Liver Health Study): Complete Statistical AnalysisIndependent statistical analysis of Team Science (The Liver Health Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06924281).
- Team-Focused Implementation in Child Advocacy Centers: Complete Statistical AnalysisIndependent statistical analysis of Team-Focused Implementation in Child Advocacy Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05679154).
- TEAM+Independent statistical analysis of Online Family Dyadic Skills Training for Black Adults in Behavioral Weight Loss Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TEAM2Independent statistical analysis of Reducing Stroke Risk in African-American Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04402125).
- TEAMMATEIndependent statistical analysis of Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TEAMS-BPIndependent statistical analysis of TEAMS-BP (The Enhancement of Social Networks to Augment Management of Stroke-Blood Pressure): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TEARIndependent statistical analysis of Treatment of Early Aggressive Rheumatoid Arthritis (TEAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00259610).
- Tecemotide (L-BLP25) in Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tecemotide (L-BLP25) in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01496131).
- TECH-EIndependent statistical analysis of Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Technology Enabled Services to Enhance Depression Care: Complete Statistical AnalysisIndependent statistical analysis of Technology Enabled Services to Enhance Depression Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05406791).
- Technology Enhanced Family Treatment: Complete Statistical AnalysisIndependent statistical analysis of Technology Enhanced Family Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03913013).
- Technology Interventions to Improve Outcomes After Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Technology Interventions to Improve Outcomes After Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04482400).
- Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients: Complete Statistical AnalysisIndependent statistical analysis of Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03771274).
- TECTONICSIndependent statistical analysis of Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…